Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting
AssigneeAbbott Laboratories
InventorsJeffrey H. Baxter, Anne C. Voss, Pradip Mukerji
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Laboratories
InventorsJeffrey H. Baxter, Anne C. Voss, Pradip Mukerji
Estimating the term…
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids.
A method of treating disease-associated wasting of a patient comprising administering to the patient a composition comprising:
Dependencies are inferred from the claim text.